Duke University and Duke-NUS Medical School are proud to announce the recipients of their latest Research Collaboration Pilot Project grants, totalling more than S$1 million.
Blueprint to pull Gavreto in certain markets, shelve EGFR programs as it focuses on Ayvakit launch
As Blueprint Medicines braces itself for a future without a major Roche collaboration, the Massachusetts biotech is pulling its RET inhibitor from certain markets and